Rescheduling cannabis to Schedule III isn’t the goal, and our work isn’t done yet. Yet, it finally cracks open a nearly ancient framework and makes way for potentially revolutionary healthcare science grounded in research while also legitimizing cannabis as medicine. We no longer have to wonder when cannabis policy will evolve; it’s now a question of when society and institutions around us will finally catch on.
Whitney Economics says U.S. cannabis operators carried more than $3.8 billion in delinquent receivables at…
Your May 2026 horoscopes arrive with intense, volatile energy, kicking off a month marked by…
Dr. Dana Lambert left hospital pharmacy in 2013 to study cannabinoid pharmacology, learned plant medicine…
In Indiana, the drugs that nearly destroyed my life were perfectly legal. Doctors administered them…
An investigation into the infrastructure, incentives, and revenue streams behind prohibition advocacy — using professional…
The LOX legend and Dynasty Commodities co-founder Rich Jospitre talk to High Times about Biggie…